Skip to main content
Log in

Analgesic Rebound Headache

How Great is the Problem and What can be Done?

  • Leading Article
  • Published:
Drug Safety Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

References

  1. Diamond S, Dalessio DJ. Drug abuse in headache. In: Diamond S, Dalessio DJ, editors. The practising physician’s approach to headache. Baltimore: Williams & Wilkins, 1982: 114–21

    Google Scholar 

  2. Wilkinson M. Introduction. In: Diener HC, Wilkinson M, editors. Drug-induced headache. Berlin: Springer-Verlag, 1988: 1–2

    Chapter  Google Scholar 

  3. Mathew NT. Drug-induced headache. Neurol Clin 1990; 8: 903–12

    PubMed  CAS  Google Scholar 

  4. Saper JR. Ergotamine dependency — a review. Headache 1987; 27: 435–8

    Article  PubMed  CAS  Google Scholar 

  5. Saper JR. Chronic headache syndromes. Neurol Clin 1989; 7: 387–412

    PubMed  CAS  Google Scholar 

  6. Saper JR, Jones JM. Ergotamine tartrate dependency: features and possible mechanisms. Clin Neuropharmacol 1986; 9: 244–56

    Article  PubMed  CAS  Google Scholar 

  7. Andersson PG. Ergotism — the clinical picture. In: Diener H-C, Wilkinson M, editors. Drug-induced headache. Berlin: Springer-Verlag, 1988: 16–9

    Chapter  Google Scholar 

  8. Rapoport AM, Weeks RE, Sheftell FD, et al. The ‘analgesic washout period’: a critical variable evaluation in the evaluation of headache treatment efficacy. Neurology 1986; 36 (1): 100–1

    Article  Google Scholar 

  9. Baumgartner C, Wessely P, Bingol C, et al. Longterm prognosis of analgesic withdrawal in patients with drug-induced headaches. Headache 1989; 29: 510–4

    Article  PubMed  CAS  Google Scholar 

  10. Mathew NT, Reuveni U, Perez F. Transformed or evolutive migraine. Headache 1987; 27: 102–6

    Article  PubMed  CAS  Google Scholar 

  11. Kudrow L. Paradoxical effects of frequent analgesic use. Adv Neurol 1982; 33: 335–41

    PubMed  CAS  Google Scholar 

  12. Rapoport AM. Analgesic rebound headache. Headache 1988; 28: 662–5

    Article  PubMed  CAS  Google Scholar 

  13. Diener HC, Dichgans J, Scholz E, et al. Analgesic-induced chronic headache: longterm results of withdrawal therapy. J Neurol 1989; 236: 9–14

    Article  PubMed  CAS  Google Scholar 

  14. Rasmussen BK, Jensen R, Olesen J. Impact of headache on sickness absence and utilization of medical services: a Danish population study. J Epidemiol Community Health 1992; 46: 443–6

    Article  PubMed  CAS  Google Scholar 

  15. Isler H. Headache drugs provoking chronic headache: historical aspects and common misunderstandings. In: Diener H-C, Wilkinson M, editors. Drug-induced headache. Berlin: Springer-Verlag, 1988: 87–94

    Chapter  Google Scholar 

  16. Wolfson W, Graham J. Development of tolerance to ergot alkaloids in a patient with unusually severe migraine. N Engl J Med 1949; 241: 296–8

    Article  PubMed  CAS  Google Scholar 

  17. Peters G, Horton B. Headache: with special reference to the excessive use of ergotamine preparations and withdrawal effect. Mayo Clin Proc 1951; 26: 153–61

    CAS  Google Scholar 

  18. Ala-Hurula V, Myllyla V, Hokkanen E. Ergotamine abuse: results of ergotamine discontinuation, with special reference to the plasma concentrations. Cephalalgia 1982; 2: 189–95

    Article  PubMed  CAS  Google Scholar 

  19. Tfelt-Hansen P, Krabbe A. Ergotamine abuse. Do patients benefit from withdrawal? Cephalalgia 1981; 1: 29–32

    Article  PubMed  CAS  Google Scholar 

  20. Dichgans J, Diener H-C. Clinical manifestations of excessive use of analgesic medication. In: Diener H-C, Wilkinson M, editors. Drug-induced headache. Berlin: Springer-Verlag, 1988: 8–15

    Chapter  Google Scholar 

  21. Mathew NT, Kurman R, Perez F. Drug induced refractory headache — clinical features and management. Headache 1990; 30: 634–8

    Article  PubMed  CAS  Google Scholar 

  22. Micieli G, Manzoni GC, Granella F, et al. Clinical and epidemiological observations on drug abuse in headache patients. In: Diener H-C, Wilkinson M, editors. Drug-induced headache. Berlin: Springer-Verlag, 1988: 20–8

    Chapter  Google Scholar 

  23. Solomon S, Lipton RB, Newman LC. Clinical features of chronic daily headache. Headache 1992; 32: 325–9

    Article  PubMed  CAS  Google Scholar 

  24. Schnider P, Aull S, Feucht M, et al. Use and abuse of analgesics in tension-type headache. Cephalalgia 1994; 14: 162–7

    Article  PubMed  CAS  Google Scholar 

  25. Silberstein SD, Saper J. Migraine: diagnosis and treatment. In: Dalessio D, Silberstein SD, editors. Wolff’s headache and other head pain. New York: Oxford University Press, 1993: 96–170

    Google Scholar 

  26. Eggen AE. The Tromsø study: frequency and predicting factors of analgesic drug use in a free-living population (12–56 years). J Clin Epidemiol 1993; 46 (11): 1297–304

    Article  PubMed  CAS  Google Scholar 

  27. Gutzwiller F, Zemp E. Der analgetikakonsum in der Bevol-kerung und socioökonomische aspekte des analgetikaabusus. In: Mihatsch MJ, editor. Das analgetikasyndrom. Stuttgart: Thieme, 1986: 197–205

    Google Scholar 

  28. Kielholz P, Ladewig D. Probleme des medikamentenmiss-brauches. Schweiz Arztezeitung 1981; 62: 2866–9

    Google Scholar 

  29. Schwarz A, Farber U, Glaeske G, et al. Daten zu analgetikakonsum and analgetikanephropathie in der bundesrepublik. Offentiches Gesundheitswesen 1985; 47: 298–300

    CAS  Google Scholar 

  30. Celentano DD, Stewart WF, Upton RB, et al. Medication use and disability among migraineurs: a national probability sample. Headache 1992; 32: 223–8

    Article  PubMed  CAS  Google Scholar 

  31. Headache Classification Committee of the International Headache Society. Classification and diagnostic criteria for headache disorders, cranial neuralgias and facial pain. Cephalalgia 1988; 8 Suppl. 7: 9–96

    Google Scholar 

  32. Robinson RG. Pain relief for headaches. Can Fam Physician 1993; 39: 867–72

    PubMed  CAS  Google Scholar 

  33. Solomon S, Lipton RB, Newman LC. Evaluation of chronic daily headache — comparison to criteria for chronic tension-type headache. Cephalalgia 1992; 12: 365–8

    Article  PubMed  CAS  Google Scholar 

  34. Messinger HB, Spierings ELH, Vincent AJP. Overlap of migraine and tension-type headache in the International Headache Society classification. Cephalalgia 1991; 11: 233–7

    Article  PubMed  CAS  Google Scholar 

  35. Silberstein SD, Lipton R, Solomon S, et al. Classification of daily and near daily headaches: proposed revisions to the IHS classification. Headache 1994; 34: 1–7

    Article  Google Scholar 

  36. Silverman K, Evans SM, Strain EC, et al. Withdrawal syndrome after the double-blind cessation of caffeine consumption. N Engl J Med 1992; 327 (16): 1109–14

    Article  PubMed  CAS  Google Scholar 

  37. Mathew NT, Stubits E, Nigam MR. Transformation of episodic migraine into daily headache: analysis of factors. Headache 1982; 22: 66–8

    Article  PubMed  CAS  Google Scholar 

  38. Diener HC, Tfelt-Hansen P. Headache associated with chronic use of substances. In: Olesen J, Tfelt-Hansen P, editors. The headaches. New York: Raven Press, 1993: 721–7

    Google Scholar 

  39. Catarci T, Fiacco F, Argentino C, et al. Ergotamine-induced headache can be sustained by sumatriptan daily intake. Cephalalgia 1994; 14: 374–5

    Article  PubMed  CAS  Google Scholar 

  40. Scholz E, Diener H-C, Geiselhart S. Drug-induced headache — does a critical dosage exist? In: Diener H-C, Wilkinson M, editors. Drug-induced headache. Berlin: Springer-Verlag, 1988: 29–43

    Chapter  Google Scholar 

  41. Saper JR. Headache disorders: current concepts in treatment strategies. Littleton, Massachusetts: Wright-PSG Publishers, 1983

    Google Scholar 

  42. Fisher CM. Analgesic rebound headache refuted. Headache 1988; 28: 666

    Article  PubMed  CAS  Google Scholar 

  43. Bowdler I, Killian J, Gänsslen-Blumberg S. The association between analgesic abuse and headache — coincidental or causal? Headache 1990; 30: 494

    Google Scholar 

  44. Lance F, Parkes C, Wilkinson M. Does analgesic abuse cause headache de novo? Headache 1988; 28 (1): 61–2

    Article  PubMed  CAS  Google Scholar 

  45. Dichgans J, Diener HC, Gerber WD, et al. Analgetika-induzier-ter dauerkopfschmerz. Dtsch Med Wochenschr 1984; 109: 369–73

    Article  PubMed  CAS  Google Scholar 

  46. Post RM, Silberstein SD. Shared mechanisms in affective illness, epilepsy, and migraine. Neurology 1994; 44 (7): S37–S47

    PubMed  CAS  Google Scholar 

  47. Isler H. Migraine treatment as a cause of chronic migraine. In: Rose FC, editor. Advances in migraine research and therapy. New York: Raven Press, 1982: 159–64

    Google Scholar 

  48. Diamond S. Depression and headache. Headache 1983; 23: 122–6

    Article  PubMed  CAS  Google Scholar 

  49. DeBenedittis G, Lorenzetti A, Pieri A. The role of stressful life events in the onset of chronic primary headache. Pain 1990; 40: 65–75

    Article  CAS  Google Scholar 

  50. Silberstein SD. Advances in understanding the pathophysiology of headache. Neurology 1992; 42 (2): 6–10

    PubMed  CAS  Google Scholar 

  51. Saper JR. Changing perspectives of chronic headache. Clin J Pain 1986; 2: 19–28

    Article  Google Scholar 

  52. Blumer D, Heilbronn M. Chronic pain as a variant of depressive disease: the pain-prone disorder. J Nerv Ment Dis 1982; 170: 425–31

    Article  PubMed  CAS  Google Scholar 

  53. Ward NG, Turner JA, Ready B, et al. Chronic pain, depression, and the dexamethasone suppression test. Pain 1992; 48: 331–8

    Article  PubMed  CAS  Google Scholar 

  54. Raskin NH. Repetitive intravenous dihydroergotamine as therapy for intractable migraine. Neurology 1986; 36: 995–7

    Article  PubMed  CAS  Google Scholar 

  55. Lipton RB, Tfelt-Hansen P. Neuroleptics. In: Olesen J, Tfelt-Hansen P, Welch KMA, editors. The headaches. New York: Raven Press Ltd, 1993: 349–359

    Google Scholar 

  56. Silberstein SD, Schulman EA, Hopkins MM. Repetitive intravenous DHE in the treatment of refractory headache. Headache 1990; 30: 334–9

    Article  PubMed  CAS  Google Scholar 

  57. Diener H-C, Gerber WD, Geiselhart S, et al. Short- and long-term effects of withdrawal therapy in drug-induced headache. In: Diener H-C, Wilkinson M, editors. Drug-induced headache. Berlin: Springer-Verlag, 1988: 133–42

    Chapter  Google Scholar 

  58. Hering R, Steiner TJ. Abrupt outpatient withdrawal of medication in analgesic-abusing migraineurs. Lancet 1991; 337: 1442–3

    Article  PubMed  CAS  Google Scholar 

  59. Diener HC, Pfaffenrath V, Soyka D, et al. Therapie des medikamenten-induzierten dauerkopfschmerzes. Münch Med Wochenschr 1992; 134: 159–62

    Google Scholar 

  60. Lake A, Saper J, Madden S, et al. Inpatient treatment for chronic daily headache: a prospective long-term outcome [abstract]. Headache 1990; 30: 299–300

    Google Scholar 

  61. Henry P, Dartigues JF, Benetier MP, et al. Ergotamine- and analgesic-induced headaches. In: Rose C, editor. Migraine. Proceedings of the 5th International Migraine Symposium. London, 1984. London: Basel Karger, 1985: 197–205

    Google Scholar 

  62. Andersson PG. Ergotamine headache. Headache 1975; 15: 118–21

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Silberstein, S.D., Young, W.B. Analgesic Rebound Headache. Drug-Safety 13, 133–144 (1995). https://doi.org/10.2165/00002018-199513030-00001

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00002018-199513030-00001

Keywords

Navigation